Not exact matches
The Freiburg
team demonstrated that the drugs sorafenib and axitinib, which are currently approved only for
kidney and liver
cancer, are effective in CML model systems as well.
The
team's insights into the origins of
kidney cancer have implications for promoting
kidney growth and regeneration.
Albiges's
team followed up on Furberg and Hakimi's work by comparing survival rates of normal weight and obese individuals with
kidney cancer that had metastasized.
At a poster session on renal
cancer, a team at the Dana - Farber Cancer Institute in Boston, Massachusetts, led by Laurence Albiges, now at Gustave Roussy near Paris, presented its findings from a study of 4,657 individuals with metastatic
cancer, a
team at the Dana - Farber
Cancer Institute in Boston, Massachusetts, led by Laurence Albiges, now at Gustave Roussy near Paris, presented its findings from a study of 4,657 individuals with metastatic
Cancer Institute in Boston, Massachusetts, led by Laurence Albiges, now at Gustave Roussy near Paris, presented its findings from a study of 4,657 individuals with metastatic
kidney
The
team found that obese people with
kidney cancer had a 53 % lower risk of dying from renal - cell carcinoma than patients who were normal weight2.
The
team's work was funded by the National
Cancer Institute, the National Institute of Diabetes and Digestive and
Kidney Diseases, and the National Institutes of Health (NIH) Common Fund.
At the Jackson Laboratory in Maine, gerontologist David Harrison and his
team chose to test rapamycin, which is already approved for use in procedures such as
kidney transplants, because previous research showed that the drug increases the life span of flies and may reduce
cancer in mammals.
Dr. Raquibul Hannan, left, and Dr. Robert Timmerman led a
team that successfully used stereotactic body radiation therapy for the first time to treat an often deadly complication of
kidney cancer.
Similarly, the
team says, those with traumatic brain injuries,
cancer, end - stage
kidney failure, complicated diabetes, heart disease, developmental disabilities and cerebral palsy need better coordination of their care across health care settings.
The
team is now examining whether there is a relationship between antioxidant nutrient intake and
kidney cancer risk in a National Cancer Institute - funded case - control study primarily conducted with participants from the metropolitan Detroit
cancer risk in a National
Cancer Institute - funded case - control study primarily conducted with participants from the metropolitan Detroit
Cancer Institute - funded case - control study primarily conducted with participants from the metropolitan Detroit area.
The
team found evidence of the process in several other cell types, including breast, ovarian, umbilical cord, and
kidney cancer cells.
Aug 8, 2008 Two New Predisposition Genes For Breast, Thyroid And
Kidney Cancers Could Lead to More Accurate Diagnosis and Earlier Detection of These
Cancers Charis Eng, MD, PhD, Sondra J and Stephen R Hardis Endowed Chair of
Cancer Genomic Medicine and Chair, GMI, and her
team published in the Aug 8, 2008 issue of the American Journal of Human Genetics that germline mutations in SDHB and SDHD, which play key roles in the mitochondria (the cell's power houses), predispose to Cowden and Cowden - like syndromes.
A total of 13 Dream
Team clinical trials are active right now, for patients with bladder
cancer,
kidney cancer, prostate
cancer, triple - negative breast
cancer, gastric
cancer, pancreatic
cancer, small cell and non-small cell lung
cancer, sarcoma, and melanoma, and seven more trials are planned.
Swanton and his
team took biopsies from four
kidney cancer patients at various locations within the same tumors, and from metastases, at different times during their course of treatments.
Affiliations: Peer Mentor — Galen College of Nursing │ «Relay For Life»
Team Leader — American
Cancer Society Volunteer — Kosair Charities │ Volunteer — National
Kidney Foundation │ Alumni — Delta Delta Delta